Unichem Laboratories, 506690, UNICHEMLAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,197.36
125.24
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,147.59
1.28%
0.87

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

3.92
-1.90
-4.27

EBITDA CAGR (%)

10 Years
5 Years
3 Years

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

15.65
0.63
-

P:BV (Average)

8 Years
5 Years
3 Years

1.95
1.68
1.00

EV:EBITDA (Average)

8 Years
5 Years
3 Years

19.83
24.78
31.80

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 311.18 231.19 34.60% 310.93 225.10 38.13% 240.77 232.52 3.55% 216.07 277.08 -22.02%
Expenses 279.54 256.90 8.81% 267.09 260.92 2.36% 248.58 250.63 -0.82% 227.05 281.89 -19.45%
EBITDA 31.64 -25.70 - 43.84 -35.82 - -7.81 -18.11 - -10.98 -4.81 -
EBIDTM 10.17% -11.12% 14.10% -15.91% -3.24% -7.79% -5.08% -1.73%
Other Income 13.32 23.01 -42.11% 10.41 29.05 -64.17% 18.73 27.98 -33.06% 19.13 22.56 -15.20%
Interest 0.61 0.42 45.24% 0.16 0.23 -30.43% 0.16 0.05 220.00% 0.59 0.41 43.90%
Depreciation 18.75 17.26 8.63% 18.93 17.86 5.99% 18.31 16.86 8.60% 19.11 17.72 7.84%
PBT 25.61 -20.37 - 35.16 -24.86 - -7.55 -7.03 - -11.54 -0.38 -
Tax -4.82 0.00 - 4.82 0.00 0 0.00 -7.50 - 0.00 -4.08 -
PAT 30.43 -20.37 - 30.34 -24.86 - -7.55 0.47 - -11.55 3.69 -
PATM 9.78% -8.81% 9.76% -11.05% -3.13% 0.20% -5.34% 1.33%
EPS 4.32 -2.89 - 4.31 -3.53 - -1.07 0.07 - -1.64 0.52 -

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 326.28 274.83 18.72% 317.51 268.14 18.41% 317.27 273.20 16.13% 320.23 374.90 -14.58%
Expenses 296.17 291.99 1.43% 287.65 294.94 -2.47% 305.19 293.42 4.01% 306.87 349.56 -12.21%
EBITDA 30.12 -17.16 - 29.86 -26.81 - 12.08 -20.22 - 13.36 25.34 -47.28%
EBIDTM 9.23% -6.24% 9.40% -10.00% 3.81% -7.40% 4.17% 6.76%
Other Income 15.61 25.10 -37.81% 10.04 28.13 -64.31% 16.71 26.26 -36.37% 11.82 20.71 -42.93%
Interest 1.27 2.32 -45.26% 0.79 1.86 -57.53% 1.25 1.28 -2.34% 2.40 4.22 -43.13%
Depreciation 20.82 19.47 6.93% 21.13 20.98 0.71% 20.54 18.25 12.55% 22.96 19.03 20.65%
PBT 23.64 -13.85 - 17.98 -21.51 - 7.00 -13.49 - -0.17 22.81 -
Tax -0.07 1.20 - 9.25 0.68 1,260.29% 4.61 -7.53 - 17.63 -9.01 -
PAT 23.71 -15.05 - 8.74 -22.19 - 2.39 -5.96 - -17.80 31.82 -
PATM 7.27% -5.48% 2.75% -8.27% 0.75% -2.18% -5.56% 8.49%
EPS 3.35 -2.07 - 1.24 -3.15 - 0.35 -0.88 - -2.44 5.40 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,078.95 904.89 975.88 1,231.38 1,418.41 1,220.52 1,090.98 1,044.17 1,005.22 803.19 764.74 Net Sales Growth 11.71% -7.27% -20.75% -13.19% 16.21% 11.87% 4.48% 3.87% 25.15% 5.03% Cost Of Goods Sold 436.68 311.23 339.36 274.57 188.07 395.62 375.39 327.82 335.81 263.68 226.54 Gross Profit 642.27 593.66 636.52 956.81 1,230.34 824.90 715.59 716.36 669.41 539.51 538.20 GP Margin 59.53% 65.61% 65.23% 77.70% 86.74% 67.59% 65.59% 68.61% 66.59% 67.17% 70.38% Total Expenditure 1,022.26 995.50 1,034.20 1,214.03 1,252.60 1,078.24 989.74 863.16 823.08 678.06 603.35 Power & Fuel Cost - 72.14 75.43 48.26 40.76 37.34 38.36 34.96 30.55 25.45 21.83 % Of Sales - 7.97% 7.73% 3.92% 2.87% 3.06% 3.52% 3.35% 3.04% 3.17% 2.85% Employee Cost - 205.16 176.76 146.54 117.68 209.60 178.04 147.14 128.01 104.88 93.07 % Of Sales - 22.67% 18.11% 11.90% 8.30% 17.17% 16.32% 14.09% 12.73% 13.06% 12.17% Manufacturing Exp. - 139.62 136.04 115.50 90.53 132.41 129.61 121.78 106.97 91.99 90.39 % Of Sales - 15.43% 13.94% 9.38% 6.38% 10.85% 11.88% 11.66% 10.64% 11.45% 11.82% General & Admin Exp. - 196.56 200.15 566.05 722.03 145.52 132.64 108.27 84.16 72.03 65.49 % Of Sales - 21.72% 20.51% 45.97% 50.90% 11.92% 12.16% 10.37% 8.37% 8.97% 8.56% Selling & Distn. Exp. - 66.88 87.17 52.96 65.40 132.40 127.44 120.75 125.03 110.10 104.08 % Of Sales - 7.39% 8.93% 4.30% 4.61% 10.85% 11.68% 11.56% 12.44% 13.71% 13.61% Miscellaneous Exp. - 3.91 19.29 10.15 28.13 25.35 8.26 2.44 12.55 9.92 104.08 % Of Sales - 0.43% 1.98% 0.82% 1.98% 2.08% 0.76% 0.23% 1.25% 1.24% 0.25% EBITDA 56.69 -90.61 -58.32 17.35 165.81 142.28 101.24 181.01 182.14 125.13 161.39 EBITDA Margin 5.25% -10.01% -5.98% 1.41% 11.69% 11.66% 9.28% 17.34% 18.12% 15.58% 21.10% Other Income 61.59 99.17 101.54 3,280.20 7.19 22.71 20.31 42.96 17.61 11.69 7.96 Interest 1.52 1.28 0.62 3.17 2.00 2.29 2.37 2.48 2.48 3.30 1.95 Depreciation 75.10 71.09 61.71 45.04 39.41 34.99 37.68 42.67 34.82 28.29 27.22 PBT 41.68 -63.81 -19.11 3,249.34 131.60 127.70 81.50 178.82 162.45 105.24 140.18 Tax 0.00 -7.50 -27.91 692.74 27.73 23.69 17.10 43.00 32.85 22.77 31.68 Tax Rate 0.00% 11.75% 146.05% 21.32% 21.07% 19.08% 20.98% 24.05% 20.22% 21.64% 22.60% PAT 41.67 -56.32 8.80 2,556.60 103.87 100.48 64.40 135.82 129.60 82.46 108.50 PAT before Minority Interest 41.67 -56.32 8.80 2,556.60 103.87 100.48 64.40 135.82 129.60 82.46 108.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.86% -6.22% 0.90% 207.62% 7.32% 8.23% 5.90% 13.01% 12.89% 10.27% 14.19% PAT Growth 201.46% - -99.66% 2,361.35% 3.37% 56.02% -52.58% 4.80% 57.17% -24.00% EPS 5.92 -8.00 1.25 363.15 14.75 14.27 9.15 19.29 18.41 11.71 15.41

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,281.29 1,210.62 1,188.19 1,379.90 1,540.06 1,332.65 1,201.79 1,133.45 1,080.80 875.46 824.04 Net Sales Growth 7.57% 1.89% -13.89% -10.40% 15.56% 10.89% 6.03% 4.87% 23.46% 6.24% Cost Of Goods Sold 419.44 308.19 364.19 274.97 188.77 386.97 378.57 332.84 343.06 278.55 237.98 Gross Profit 861.85 902.43 823.99 1,104.93 1,351.28 945.67 823.23 800.61 737.75 596.91 586.07 GP Margin 67.26% 74.54% 69.35% 80.07% 87.74% 70.96% 68.50% 70.63% 68.26% 68.18% 71.12% Total Expenditure 1,195.88 1,261.44 1,269.21 1,358.21 1,357.62 1,168.77 1,100.79 955.75 910.06 759.42 674.08 Power & Fuel Cost - 73.02 76.39 49.23 41.62 38.25 39.39 35.97 31.36 26.22 22.50 % Of Sales - 6.03% 6.43% 3.57% 2.70% 2.87% 3.28% 3.17% 2.90% 2.99% 2.73% Employee Cost - 273.28 238.52 200.64 169.04 255.92 223.20 187.37 164.88 140.06 123.99 % Of Sales - 22.57% 20.07% 14.54% 10.98% 19.20% 18.57% 16.53% 15.26% 16.00% 15.05% Manufacturing Exp. - 151.01 147.23 125.30 103.70 150.54 145.03 137.05 119.15 101.54 102.67 % Of Sales - 12.47% 12.39% 9.08% 6.73% 11.30% 12.07% 12.09% 11.02% 11.60% 12.46% General & Admin Exp. - 228.99 229.37 594.53 744.66 167.66 153.29 127.77 104.73 88.54 79.74 % Of Sales - 18.92% 19.30% 43.09% 48.35% 12.58% 12.76% 11.27% 9.69% 10.11% 9.68% Selling & Distn. Exp. - 223.02 197.24 108.38 107.77 166.84 157.12 134.03 135.93 116.00 106.52 % Of Sales - 18.42% 16.60% 7.85% 7.00% 12.52% 13.07% 11.82% 12.58% 13.25% 12.93% Miscellaneous Exp. - 3.93 16.26 5.16 2.06 2.58 4.19 0.73 10.97 8.50 106.52 % Of Sales - 0.32% 1.37% 0.37% 0.13% 0.19% 0.35% 0.06% 1.01% 0.97% 0.08% EBITDA 85.42 -50.82 -81.02 21.69 182.44 163.88 101.00 177.70 170.74 116.04 149.96 EBITDA Margin 6.67% -4.20% -6.82% 1.57% 11.85% 12.30% 8.40% 15.68% 15.80% 13.25% 18.20% Other Income 54.18 91.31 98.41 3,278.19 5.50 19.11 20.72 42.38 16.96 12.50 8.32 Interest 5.71 7.85 7.52 8.01 3.36 2.90 3.04 3.19 3.29 4.08 2.39 Depreciation 85.45 81.67 67.37 50.51 43.52 38.79 41.27 45.72 38.34 30.43 29.22 PBT 48.45 -49.02 -57.50 3,241.36 141.07 141.31 77.41 171.17 146.07 94.03 126.66 Tax 31.42 11.97 -33.64 696.23 32.58 29.30 2.13 43.00 32.85 22.77 31.68 Tax Rate 64.85% -24.42% 58.50% 21.48% 23.09% 21.27% 2.75% 25.12% 22.49% 24.22% 25.01% PAT 17.04 -61.00 -23.87 2,545.13 108.49 108.48 75.28 128.16 113.23 71.26 94.98 PAT before Minority Interest 17.04 -61.00 -23.87 2,545.13 108.49 108.48 75.28 128.16 113.23 71.26 94.98 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.33% -5.04% -2.01% 184.44% 7.04% 8.14% 6.26% 11.31% 10.48% 8.14% 11.53% PAT Growth 249.74% - - 2,245.96% 0.01% 44.10% -41.26% 13.19% 58.90% -24.97% EPS 2.42 -8.66 -3.39 361.52 15.41 15.41 10.69 18.20 16.08 10.12 13.49

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 2,647.18 2,731.93 2,761.67 1,130.73 1,027.15 947.42 906.27 812.95 730.05 678.02 Share Capital 14.08 14.08 14.07 18.18 18.17 18.15 18.13 18.09 18.06 18.05 Total Reserves 2,628.28 2,714.02 2,747.01 1,111.11 1,007.83 928.41 887.39 793.86 711.27 659.17 Non-Current Liabilities 29.68 26.79 50.07 70.40 63.66 69.27 73.08 73.42 72.20 68.43 Secured Loans 0.00 0.00 0.33 0.44 0.46 0.22 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.49 22.72 Long Term Provisions 23.51 14.60 10.76 25.33 12.58 8.88 7.64 9.19 10.24 7.90 Current Liabilities 348.27 271.50 295.88 301.81 282.61 205.00 227.27 246.34 224.19 169.20 Trade Payables 208.22 192.69 211.51 228.28 189.63 142.63 151.13 159.09 136.78 106.92 Other Current Liabilities 115.02 67.56 60.40 56.73 47.43 36.32 29.71 29.87 29.23 22.69 Short Term Borrowings 15.21 0.00 0.00 0.55 7.90 0.00 0.63 5.72 24.87 8.47 Short Term Provisions 9.81 11.25 23.97 16.25 37.65 26.05 45.80 51.67 33.30 31.13 Total Liabilities 3,025.13 3,030.22 3,107.62 1,502.94 1,373.42 1,221.69 1,206.62 1,132.71 1,026.44 915.65 Net Block 824.94 785.16 551.12 464.17 381.20 395.87 393.72 426.22 385.21 355.64 Gross Block 1,037.52 939.38 655.08 535.64 414.65 683.53 642.30 637.46 562.43 504.43 Accumulated Depreciation 212.58 154.22 103.96 71.47 33.45 287.67 248.58 211.24 177.22 148.78 Non Current Assets 1,520.42 1,177.12 895.56 815.69 744.42 676.73 642.69 671.09 614.20 513.66 Capital Work in Progress 330.84 90.25 235.53 247.26 232.65 118.66 86.31 129.29 111.34 62.87 Non Current Investment 252.77 245.36 86.97 85.16 102.52 117.61 114.25 107.20 91.62 78.85 Long Term Loans & Adv. 111.88 56.36 21.94 19.11 28.05 44.59 48.42 8.38 26.02 16.29 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,504.71 1,853.10 2,212.05 687.25 629.00 544.95 563.92 461.63 412.25 402.00 Current Investments 419.10 800.75 895.55 8.00 8.04 35.04 5.67 33.06 14.50 21.29 Inventories 315.57 274.18 207.76 253.98 200.66 186.48 186.24 131.63 141.13 135.42 Sundry Debtors 323.10 331.35 231.74 296.49 264.73 206.19 211.28 212.28 184.82 183.94 Cash & Bank 205.37 191.03 673.61 10.16 10.94 19.71 40.83 16.66 13.86 10.44 Other Current Assets 241.57 63.63 57.89 18.21 144.63 97.52 119.92 68.00 57.93 50.91 Short Term Loans & Adv. 182.77 192.16 145.51 100.40 121.55 80.97 103.50 59.71 51.11 45.60 Net Current Assets 1,156.45 1,581.60 1,916.17 385.44 346.38 339.96 336.65 215.28 188.06 232.79 Total Assets 3,025.13 3,030.22 3,107.61 1,502.94 1,373.42 1,221.68 1,206.61 1,132.72 1,026.45 915.66

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 2,531.35 2,619.91 2,680.08 1,063.62 954.33 867.52 816.61 727.07 660.58 617.70 Share Capital 14.08 14.08 14.07 18.18 18.17 18.15 18.13 18.09 18.06 18.05 Total Reserves 2,512.44 2,601.99 2,665.42 1,044.00 935.01 848.52 797.74 707.98 641.80 598.85 Non-Current Liabilities 43.72 10.10 46.46 64.49 76.02 74.21 97.72 94.31 92.67 87.44 Secured Loans 0.00 0.00 0.33 0.44 22.98 20.35 24.65 20.89 20.47 19.01 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.49 22.72 Long Term Provisions 23.51 14.60 10.76 25.33 12.58 8.88 7.64 9.19 10.24 7.90 Current Liabilities 566.73 502.92 463.51 392.62 275.09 211.76 230.32 251.12 233.30 176.15 Trade Payables 250.22 221.41 226.23 210.73 163.95 138.23 150.52 156.63 140.30 109.99 Other Current Liabilities 122.04 68.45 63.03 68.01 60.56 45.86 32.99 36.65 34.28 26.00 Short Term Borrowings 184.03 199.67 150.29 97.62 12.93 1.63 1.04 6.17 25.42 9.04 Short Term Provisions 10.44 13.39 23.97 16.25 37.65 26.05 45.78 51.67 33.30 31.13 Total Liabilities 3,141.80 3,132.93 3,190.05 1,520.73 1,305.44 1,153.49 1,144.65 1,072.50 986.55 881.29 Net Block 866.06 806.29 574.45 487.22 402.60 415.99 419.29 447.76 408.39 377.31 Gross Block 1,103.64 975.96 689.74 561.37 439.53 724.65 688.25 675.87 599.27 537.04 Accumulated Depreciation 237.59 169.67 115.29 74.15 36.92 308.66 268.96 228.11 190.87 159.73 Non Current Assets 1,455.33 1,093.64 853.59 772.27 673.34 589.07 563.97 594.06 547.20 456.50 Capital Work in Progress 330.47 92.39 238.15 249.98 237.13 122.64 90.54 132.20 112.76 62.87 Non Current Investment 134.38 129.20 9.20 9.51 5.54 5.83 5.72 5.72 0.03 0.03 Long Term Loans & Adv. 112.90 56.37 24.05 25.57 28.05 44.61 48.42 8.38 26.02 16.29 Other Non Current Assets 11.52 9.39 7.74 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,686.47 2,039.29 2,336.47 748.46 632.11 564.42 580.68 478.44 439.35 424.79 Current Investments 419.10 800.75 895.55 8.00 8.04 35.04 5.67 33.06 14.50 21.29 Inventories 396.54 338.66 272.86 281.71 230.57 207.68 203.49 143.05 157.96 150.26 Sundry Debtors 390.14 436.05 276.92 315.32 220.09 191.58 196.51 206.95 183.25 185.13 Cash & Bank 233.81 200.99 681.46 16.14 20.13 26.96 52.15 24.64 23.23 15.16 Other Current Assets 246.88 68.65 64.17 28.49 153.28 103.17 122.86 70.75 60.40 52.95 Short Term Loans & Adv. 183.04 194.18 145.51 98.80 122.77 82.25 105.67 61.73 53.14 47.14 Net Current Assets 1,119.74 1,536.37 1,872.95 355.84 357.02 352.66 350.36 227.32 206.05 248.65 Total Assets 3,141.80 3,132.93 3,190.06 1,520.73 1,305.45 1,153.49 1,144.65 1,072.50 986.55 881.29

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -41.84 -251.30 -66.25 140.78 116.58 88.03 86.87 180.30 129.26 80.60 PBT -63.81 -19.11 3,249.34 131.60 124.17 81.50 178.82 162.45 105.24 140.18 Adjustment -6.17 -7.08 -3,214.36 72.37 56.10 36.30 20.38 46.82 37.81 26.45 Changes in Working Capital 25.49 -217.91 -103.24 -35.89 -32.73 -11.59 -74.94 5.77 8.92 -55.28 Cash after chg. in Working capital -44.49 -244.10 -68.27 168.08 147.55 106.21 124.26 215.04 151.97 111.35 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 2.65 -7.20 2.01 -27.30 -30.97 -18.17 -37.39 -34.74 -22.71 -30.75 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -35.59 -322.63 1,648.30 -131.91 -86.73 -62.18 35.22 -126.60 -110.97 -53.44 Net Fixed Assets -338.73 -139.02 -107.71 -135.60 154.89 -73.58 38.14 -92.98 -106.47 -67.03 Net Investments 374.24 -63.59 -889.36 17.40 42.09 -32.73 20.34 -34.14 -5.98 28.17 Others -71.10 -120.02 2,645.37 -13.71 -283.71 44.13 -23.26 0.52 1.48 -14.58 Cash from Financing Activity -21.02 -44.89 -929.51 -8.95 -38.63 -46.97 -97.92 -50.90 -14.87 -35.78 Net Cash Inflow / Outflow -98.45 -618.82 652.53 -0.08 -8.77 -21.12 24.17 2.80 3.42 -8.62 Opening Cash & Equivalents 188.66 660.31 7.77 7.86 19.71 40.83 16.66 13.86 10.44 19.06 Closing Cash & Equivalent 203.08 188.66 660.31 7.77 10.94 19.71 40.83 16.66 13.86 10.44

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 19.82 -327.77 -112.34 68.19 111.91 78.10 86.73 171.23 124.08 68.59 PBT -48.21 -57.44 3,241.14 141.25 137.68 77.41 171.17 146.07 94.03 126.66 Adjustment 18.79 6.80 -3,207.66 53.31 39.65 35.57 18.74 47.15 39.37 27.54 Changes in Working Capital 53.58 -264.94 -146.67 -98.65 -34.16 -16.49 -66.32 13.05 13.51 -54.81 Cash after chg. in Working capital 24.15 -315.57 -113.20 95.91 143.16 96.49 123.58 206.27 146.91 99.39 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.34 -12.20 0.86 -27.72 -31.25 -18.39 -36.85 -35.04 -22.83 -30.81 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -41.21 -286.01 1,648.33 -127.87 -85.33 -52.34 35.70 -118.45 -101.80 -47.60 Net Fixed Assets -338.73 -139.02 -107.71 -135.60 154.89 -73.58 38.14 -92.98 -106.47 -67.03 Net Investments 374.24 -63.59 -889.36 17.40 42.09 -32.73 20.34 -34.14 -5.98 28.17 Others -76.72 -83.40 2,645.40 -9.67 -282.31 53.97 -22.78 8.67 10.65 -8.74 Cash from Financing Activity -62.30 -2.42 -881.13 59.23 -33.42 -50.95 -94.92 -51.38 -14.21 -29.46 Net Cash Inflow / Outflow -83.69 -616.19 654.86 -0.46 -6.84 -25.19 27.51 1.41 8.07 -8.48 Opening Cash & Equivalents 197.05 666.07 11.21 11.67 26.96 52.15 24.64 23.23 15.16 23.64 Closing Cash & Equivalent 226.22 197.05 666.07 11.21 20.13 26.96 52.15 24.64 23.23 15.16

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 375.30 387.60 392.55 124.27 112.94 104.28 99.92 89.76 80.75 75.05 ROA -1.86% 0.29% 110.90% 7.22% 7.74% 5.30% 11.61% 12.00% 8.49% 12.44% ROE -2.10% 0.32% 131.43% 9.64% 10.19% 6.95% 15.82% 16.82% 11.73% 16.86% ROCE -2.32% -0.67% 167.06% 12.33% 12.75% 9.04% 21.01% 20.65% 14.59% 21.17% Fixed Asset Turnover 0.92 1.22 2.07 2.99 2.25 1.66 1.64 1.69 1.52 1.64 Receivable days 131.99 105.30 78.26 72.16 69.53 69.33 73.49 71.54 83.25 82.07 Inventory Days 118.94 90.13 68.41 58.46 57.16 61.90 55.15 49.14 62.43 55.22 Payable days 82.50 82.64 118.77 140.05 63.62 59.84 69.69 71.38 71.47 69.28 Cash Conversion Cycle 168.43 112.80 27.91 -9.43 63.06 71.39 58.95 49.31 74.22 68.01 Total Debt/Equity 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.07 0.05 Interest Cover -48.78 -29.97 1027.03 66.88 55.19 35.41 73.06 66.46 32.90 72.95

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 358.85 371.69 380.95 116.88 104.93 95.48 90.02 80.27 73.06 68.36 ROA -1.94% -0.75% 108.06% 7.68% 8.82% 6.55% 11.56% 11.00% 7.63% 11.31% ROE -2.37% -0.90% 136.04% 10.77% 11.92% 8.95% 16.62% 16.34% 11.16% 16.11% ROCE -1.49% -1.77% 162.77% 13.42% 14.97% 9.29% 21.84% 20.13% 14.03% 20.37% Fixed Asset Turnover 1.16 1.43 2.21 3.08 2.32 1.71 1.67 1.71 1.55 1.66 Receivable days 124.55 109.51 78.30 63.41 55.72 58.55 64.53 65.42 76.34 77.46 Inventory Days 110.83 93.93 73.33 60.67 59.32 62.03 55.42 50.47 63.88 56.72 Payable days 74.71 73.41 94.97 104.25 52.00 52.61 62.52 65.77 65.64 63.82 Cash Conversion Cycle 160.67 130.03 56.65 19.82 63.05 67.97 57.43 50.11 74.58 70.36 Total Debt/Equity 0.07 0.08 0.06 0.09 0.04 0.03 0.03 0.04 0.11 0.08 Interest Cover -5.25 -6.64 405.79 43.00 48.57 26.45 54.66 45.40 24.06 53.94

Top Investors:

hdfc small cap fund

krishnaraj venkataraman

iepf

Annual Reports:

News Update:

Unichem Laboratories gets nod for Guanfacine Tablets
4th Mar 2021, 16:08 PM

The product will be commercialized from Unichem’s Ghaziabad Plant
Read More
Unichem Laboratories gets approval for Apremilast Tablets
19th Feb 2021, 11:20 AM

Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
Read More
Unichem Laboratories gets approval for Zonisamide Capsules
27th Jan 2021, 16:44 PM

The product will be commercialized from Unichem’s Goa Plant
Read More
Unichem Laboratories gets ANDA approval for Celecoxib Capsules
13th Jan 2021, 12:54 PM

The product will be commercialized from Unichem’s Goa Plant
Read More
ICRA reaffirms Unichem Laboratories’ long-term rating
8th Jan 2021, 15:58 PM

The outlook on the long term rating has been revised to stable from negative
Read More

Unichem Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 506690 | NSE: UNICHEMLAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Unichem Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 506690 | NSE: UNICHEMLAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: